OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real‐world evidence for the long‐term effect of allergen immunotherapy: Current status on database‐derived European studies
Christian Vogelberg, Ludger Klimek, Bernd Brüggenjürgen, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3584-3592
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
Yuming Sun, Liping Jin, Yating Dian, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101981-101981
Open Access | Times Cited: 48

Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well‐Tolerated in a Pivotal Phase III Trial
Stefan Zielen, Jonathan A. Bernstein, Gunter J. Sturm, et al.
Allergy (2025)
Open Access | Times Cited: 2

Hot topics in allergen immunotherapy, 2023: Current status and future perspective
Magdalena Zemelka‐Wiącek, Ioana Agache, Cezmi A. Akdiş, et al.
Allergy (2023) Vol. 79, Iss. 4, pp. 823-842
Open Access | Times Cited: 27

House dust mite SCIT reduces asthma risk and significantly improves long‐term rhinitis and asthma control—A RWE study
Marek Jutel, Ludger Klimek, Hartmut Richter, et al.
Allergy (2024) Vol. 79, Iss. 4, pp. 1042-1051
Open Access | Times Cited: 10

Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)
P. Démoly, Mathiéu Molimard, Jean‐François Bergmann, et al.
The Lancet Regional Health - Europe (2024) Vol. 41, pp. 100915-100915
Open Access | Times Cited: 9

Immunomodulatory properties of mesenchymal stem cells: A potential therapeutic strategy for allergic rhinitis
Ming Wang, Ning Zhao, Chengshuo Wang, et al.
Allergy (2023) Vol. 78, Iss. 6, pp. 1425-1440
Open Access | Times Cited: 20

Allergen immunotherapy in asthma
Kazuyuki Nakagome, Makoto Nagata
Allergology International (2024) Vol. 73, Iss. 4, pp. 487-493
Open Access | Times Cited: 5

Prevention Is Better than Cure: Impact of Allergen Immunotherapy on the Progression of Airway Disease
Syed Hasan Arshad, Gideon Lack, Stephen R. Durham, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 12, Iss. 1, pp. 45-56
Closed Access | Times Cited: 11

The data-intensive research paradigm: challenges and responses in clinical professional graduate education
Chunhong Yang, Yijing Chen, Changshun Qian, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access

A dominant, pan-DR binding epitope of Der p 1 in house dust mite allergy induces tolerance in HLA-DR4 transgenic mice
Heather B. Streeter, Lidia de Lucas, Robert West, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark
Peter Bager, Gry Poulsen, Jan Wohlfahrt, et al.
Allergy (2024) Vol. 79, Iss. 4, pp. 1028-1041
Open Access | Times Cited: 3

Preventive allergen immunotherapy with inhalant allergens in children
Varsha Dwivedi, Sonja Kopanja, Klara Schmidthaler, et al.
Allergy (2024) Vol. 79, Iss. 8, pp. 2065-2087
Open Access | Times Cited: 3

New progress in pediatric allergic rhinitis
Miao Cheng, Qianqian Dai, Zhi Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Long‐term effects of pollen allergoid tyrosine‐adsorbed subcutaneous immunotherapy on allergic rhinitis and asthma
Christian Vogelberg, Ludger Klimek, Silvia Kruppert, et al.
Clinical & Experimental Allergy (2023) Vol. 54, Iss. 4, pp. 253-264
Open Access | Times Cited: 4

Immunotherapy against environmental fungi causing respiratory allergy
Umut Gazi, Nerin N. Bahçeciler
Journal de Mycologie Médicale (2024) Vol. 34, Iss. 4, pp. 101517-101517
Closed Access | Times Cited: 1

Allergy Immunotherapy: State of the Art
Harold S. Nelson
Current Treatment Options in Allergy (2023) Vol. 10, Iss. 2, pp. 166-183
Closed Access | Times Cited: 2

A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort
Philippe Devillier, Mathiéu Molimard, Jean‐François Bergmann, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 4, pp. 405-412
Open Access | Times Cited: 2

The state of allergen-specific immunotherapy in Russia
Yu. S. Smolkin
Allergology and Immunology in Pediatrics (2024), Iss. 2, pp. 5-8
Open Access

Allergen immunotherapy adverse events in adults with respiratory allergies‐data from ADER: An EAACI task force report
Julijana Asllani, Dimitrios Mitsias, George Ν. Konstantinou, et al.
Allergy (2024)
Closed Access

Predicting allergen immunotherapy efficacy based on early maintenance phase response in routine clinical practice
Rundong Qin, Wanyi Fu, Renbin Huang, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 12, pp. 100986-100986
Closed Access

Page 1 - Next Page

Scroll to top